Feeds:
Posts
Comments

Archive for the ‘Enlarged prostate’ Category

TURP is useful for diagnosing early stage prostate cancer

Posted in Diagnosis, Enlarged prostate, PROSTATE CANCER, PROSTATE RESEARCH, Trans-urethral re-section, Urination, tagged , , , , , , , , , , , , , , , , , , on June 20, 2010 | Leave a Comment »

URO TODAY: Benign prostatic hyperplasia patients in whom prostate cancer is suspected and who have urination problems, with a previously negative biopsy result, can undergo transurethral resection of the prostate, which treats bladder outlet obstruction and gives early diagnosis of prostate cancer. READ MORE>

Read Full Post »

Combo drug for prostatic hyperplasia in men with enlarged prostate

Posted in Enlarged prostate, PROSTATE CANCER, tagged , , , , , , , , , on June 17, 2010 | Leave a Comment »

PHARMA TIMES: US regulators have approved GlaxoSmithKline’s combination drug, Jalyn, to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate. READ MORE>

Read Full Post »

PERSONAL STORY: When prostate rules it’s not OK

Posted in Doctors' advice, Enlarged prostate, Good news recovery stories, Incontinence, PROSTATE CANCER, Prostate stories, PSA tests, Urination, tagged , , , , , , , , , , , , , , , , on September 21, 2009 | Leave a Comment »

DOMINION POST: In this personal account, a Lower Hutt man recalls the dire effects on his life of an enlarged prostate – and how he finally got it fixed.

When prostate rules it’s not OK

…was too late. I was in trouble again – this time on an island miles from a hospital. I returned in some discomfort to the company and tried to act as if everything was OK. We left soon after. When we got to the cottage I sat on the toilet until I got…read more…

Read Full Post »

New drug for treating benign prostatic hyperplasia enters phase 2 clinical trial in US

Posted in Enlarged prostate, PROSTATE CANCER, Treatment news, tagged , , , , , , , , , , , , , on August 20, 2009 | Leave a Comment »

BIO-MEDICINE: The first patients have entered a Phase 2 clinical trial of a innovative targeted drug treatment, Aptocine(TM) (talaporfin sodium), for benign prostatic hyperplasia (enlarged prostate). READ MORE>

Read Full Post »

PROSTATE RESEARCH: Surgery for benign enlarged prostate doesn’t eliminate cancer risk

Posted in Enlarged prostate, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged , , , , , , , , , , , , on June 20, 2009 | Leave a Comment »

JUNE 20: URO TODAY: Men undergoing surgical interventions for benign enlarged prostate are still at risk for subsequent development of prostate cancer due to residual tissue. READ MORE>

Read Full Post »

PROSTATE EXAMS: Doctor writes about wierd way he was taught to do digital exams

Posted in Checkups, Diagnosis, Digital exams, Enlarged prostate, PROSTATE CANCER, tagged , , , , , , , , on May 26, 2009 | Leave a Comment »

MAY 26:  TALES FROM SERENITY NOW HOSPITAL:  How some (semi-literate) US doctors learn to perform digital examinations on patients – a bizarre tale:  “The patient (sic) recieved 100 dollars per five rectals or 20 bucks each finger. Many of these patients smelled of alcohol, had no teeth, had mental illnesses, and were addicted to IV drugs…” READ MORE>

Read Full Post »

PROSTATE RESEARCH: Drug used for enlarged prostate also reduces cancer risk

Posted in Enlarged prostate, PROSTATE CANCER, PROSTATE RESEARCH, Treatment news, tagged , , , , , , , , , on April 29, 2009 | Leave a Comment »

BIO-MEDICINE: Dutasteride (Avodart), a commonly prescribed drug to treat benign prostatic hyperplasia, has been shown to lower the risk of prostate cancer by 23 percent in men with an increased risk of the disease, according to results of an international clinical trial presented yesterday at the American Urological Association annual meeting in Chicago. READ MORE>

Read Full Post »